Impact of the Antihistamine Desloratadine on the Quality of Life and Dysmenorrhea in Patients With Endometriosis

NCT07821320 · ctgov not_yet_recruiting phase phase-2

Enrollment: 60
Start: 2027-02-01
Completion: 2028-05-01
Last updated: 2026-09-18
Has results: False
Countries: Austria

Conditions

EndometriosisEndometriosis (Diagnosis)Endometriosis and DysmenorrheaEndometriosis Associated Pelvic Pain

Tagged with

endometriosis

Interventions

Desloratadine DRUG
5mg daily
Placebo DRUG
Placebo

Eligibility criteria

Inclusion Criteria: * Female patients aged 18-50 * By imaging (sonography or MRI) or surgery last 10 years confirmed endometriosis * EHP-30 Score \> 40 Exclusion Criteria: * Subject is unable or unwilling to participate * History of malignant diseases * Current immunosuppressant treatment * History of allergies and/or usage of antihistaminic treatments * Postmenopausal women * Current hormonal treatment * Surgical treatment \<1year

License: public-domain-us · commercial use OK · attribution required
Courtesy of ClinicalTrials.gov / U.S. National Library of Medicine